Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Reperfusion Injury/pathology/physiopathology/*prevention & control"'
Autor:
Otmar Trentz, Guido A. Wanner, Michael D. Menger, Claudio Contaldo, Ahmed Elsherbiny, Christoph A. Meier, Yves Harder
Publikováno v:
American Journal of Physiology. Heart and Circulatory Physiology, Vol. 293, No 1 (2007) pp. H274-83
Erythropoietin (EPO) has been proposed as a novel cytoprotectant in ischemia-reperfusion (I/R) injury of the brain, heart, and kidney. However, whether EPO exerts its protection by prevention of postischemic microcirculatory deterioration is unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de5818dd4dd83ad87d78b32165c6e8b7
https://archive-ouverte.unige.ch/unige:34866
https://archive-ouverte.unige.ch/unige:34866